16:02 Dec 20
Eris Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Eris Lifesciences Ltd.
Industry Pharmaceuticals
16:02 Dec 20
Quality
43/100
Medium Financial Strength
Valuation
23/100
Expensive Valuation
Technical
59/100
Technically Neutral
Strength
5
Weakness
7
Opportunity
0
Threats
0
18.79K
Market Cap (Cr)
53.92
PE Ratio
6.78
Price to Book Ratio
42.17
RSI
19.50 %
Net Profit Margin
Download Our App On:
